P2RX4 and obesity disorder: We found that imperatorin or P2X4 shRNA treatment had mitigating effects on the degree of obesity, abnormalities in blood pressure, increases in heart rate variability, abnormal cardiac sympathetic nerve activity, and the elevation of serum TG, T-CHO, and LDH-L levels in obese rats.